New strategy aims to get lifesaving heart drugs to more patients

NCT ID NCT05990296

Completed Disease control Sponsor: Geisinger Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested whether special alerts in electronic health records and referrals to pharmacists could help doctors prescribe guideline-recommended heart failure medications more often. Over 4,300 patients with heart failure and reduced ejection fraction took part. The goal was to increase use of drugs that can reduce hospitalizations and improve survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral intervention: clinical decision support tools and pharmacist co-management
What this could lead to: If successful, this approach could help more heart failure patients get the right medications, potentially reducing hospitalizations and deaths.
What could go wrong: This is a completed implementation study, not a drug trial. The strategies may not work in other healthcare systems or may not change long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE HEART FAILURE WITH REDUCED EJECTION FRACTION

Contacts and locations

Locations

Geisinger Cardiology Clinics

Danville, Pennsylvania, 17822, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.